Pablo Arija

机构：GGD Rotterdam-Rijnmond

发表论文 1 篇 · 总被引 2 次 · h-index 1

代表论文

• Axi-cel delivers similar outcomes regardless of ASCT-eligibility in second line R/R LBCL: Combined data from ZUMA-7 and ALYCANTE (2025 · Blood · 被引 2)